New malaria vaccine candidate tested in UK volunteers
⭐️ VACCINE ⭐️
Terminated
This early-stage study tested a new vaccine against Plasmodium vivax malaria in 25 healthy adults in the UK. The vaccine, Pvs25-IMX313 with Matrix-M1 adjuvant, was given to see if it is safe and triggers an immune response. The study was terminated early, so results are limited.
Phase: EARLY_PHASE1 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:56 UTC